Skip to main content

Table 4 The association between the combined SNPs and allopurinol-induced cADRs vs. the tolerant controls

From: Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

HLA/SNPs allele

cADRs vs. tolerant control

SJS-TEN vs. tolerant control

DRESS vs. tolerant control

MPE vs. tolerant control

Odds ratio

(95%CI)

P-value

Odds ratio

(95%CI)

P-value

Odds ratio

(95%CI)

P-value

Odds ratio

(95%CI)

P-value

HLA-B*58:01

137.2

(38.3–670.5)

1.7 × 10− 27

582.0 (62.2–5447.3)

3.7 × 10− 23

92.2

(22.6–375.1)

2.3 × 10− 14

63.7

(8.4–829.2)

2.7 × 10− 6

rs3099844, C > A

rs9263726,G > A

53.1

(18.9–170.3)

2.2 × 10− 22

200.9

(27.6–8484.4)

7.5 × 10− 17

42.9

(11.5–208.9)

3.0 × 10− 12

3.4

(0.5–17.3)

1.1 × 10− 1

rs3099844, C > A

rs9263726,G > A

rs9263733, C > T

73.2

(24.2–266.8)

1.9 × 10− 24

200.9

(27.6–8484.4)

7.5 × 10− 17

42.9

(11.5–208.9)

3.0 × 10− 12

14.5

(2.4 -107.6)

1.1 × 10− 3

rs3099844, C > A

rs9263726,G > A

rs9263733, C > T

rs9263745, G > A

73.2

(24.2–266.8)

1.9 × 10− 24

200.9

(27.6–8484.4)

7.5 × 10− 17

42.9

(11.5–208.9)

3.0 × 10− 12

25.7

(3.9–291.3)

9.3 × 10− 5

rs3099844, C > A

rs9263726,G > A

rs9263733, C > T

rs9263745, G > A

rs4084090, A > G

56.9

(18.9–214.6)

3.4 × 10− 22

129.9

(18.6–5505.9)

1.4 × 10− 14

38.3

(9.8–224.8)

2.0 × 10− 11

16.4

(2.6–181.7)

5.7 × 10− 4

  1. Abbreviations cutaneous adverse drug reactions, cADRs; Stevens-Johnson syndrome, SJS; toxic epidermal necrolysis, TEN; drug reaction with eosinophilia and systemic symptoms, DRESS; maculopapular exanthema, MPE; SNPs, Single nucleotide polymorphisms; and 95% CI, 95% Confidence Interval